Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Meeting abstracts from the Annual Conference "Clinical Genetics of Cancer 2022". | Hered Cancer Clin Pract | 2023 | 37434214 | PubTator, text mining | PubMed |
| Identifying important microbial and genomic biomarkers for differentiating right- versus left-sided colorectal cancer using random forest models. | BMC Cancer | 2023 | 37434131 | PubTator, text mining | PubMed |
| Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers. | Nat Commun | 2023 | 37419892 | PubTator, text mining | PubMed |
| Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes. | J Transl Med | 2023 | 37415201 | PubTator, text mining | PubMed |
| Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice? | BJU Int | 2023 | 37410655 | PubTator, text mining | PubMed |
| Hierarchical Phosphorylation of HOXB13 by mTOR Dictates Its Activity and Oncogenic Function in Prostate Cancer. | Mol Cancer Res | 2023 | 37409967 | PubTator, text mining | PubMed |
| Genomic and transcriptional characterization of early esophageal squamous cell carcinoma. | BMC Med Genomics | 2023 | 37393256 | PubTator, text mining | PubMed |
| Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer. | BMC Cancer | 2023 | 37391697 | PubTator, text mining | PubMed |
| Peripheral Neuron-Organoid Interaction Induces Colonic Epithelial Differentiation via Non-Synaptic Substance P Secretion. | Int J Stem Cells | 2023 | 37385635 | PubTator, text mining | PubMed |
| Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. | Development | 2023 | 37376888 | PubTator, text mining | PubMed |
| Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma. | Cancers (Basel) | 2023 | 37370768 | PubTator, text mining | PubMed |
| The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer. | Cancers (Basel) | 2023 | 37370720 | PubTator, text mining | PubMed |
| Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics. | Cancer Metastasis Rev | 2023 | 37369946 | PubTator, text mining | PubMed |
| Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia. | Front Med (Lausanne) | 2023 | 37359019 | PubTator, text mining | PubMed |
| HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development. | Compr Physiol | 2023 | 37358518 | PubTator, text mining | PubMed |
| Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex. | Cancer Res | 2023 | 37352376 | PubTator, text mining | PubMed |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. | Anticancer Res | 2023 | 37351993 | PubTator, text mining | PubMed |
| GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. | Cancers (Basel) | 2023 | 37345060 | PubTator, text mining | PubMed |
| The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. | Cancer Res | 2023 | 37289025 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. | Front Pharmacol | 2023 | 37284313 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=13